Actinium Pharmaceuticals, Inc
$1.19
Market Cap
$37.42M
Shares Outstanding
31.4M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jul 19, 2007
Round Lot
100
Locale
US
Day Open
$1.26
Day High
$1.26
Day Low
$1.18
Volume
57.0K
VWAP
$1.22
Prev Close
$1.24
Transactions
--
Acc. Volume
--
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.
Actinium Pharmaceuticals, Inc (ATNM) closed the 2026-09-17 session at $1.19, down 4.03% versus the previous close (-0.05). The stock opened at $1.26 and traded between $1.18 and $1.26 during that session. Session trading volume was 57K shares. The volume-weighted average price (VWAP) is $1.22.
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.
Actinium Pharmaceuticals, Inc has a market capitalization of $37.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ATNM is listed on the XASE exchange. The company employs approximately 25 people. Actinium Pharmaceuticals, Inc is headquartered in NEW YORK, NY. The recorded listing date is 2007-07-19.
On this page you can find market ATNM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.